FDA Inspection 1319506 — Andrology Laboratory Services, Inc
The FDA completed an inspection of Andrology Laboratory Services, Inc on May 27, 2026 in Oakbrook Terrace, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 27, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Oakbrook Terrace, IL (United States)